Treatment of the ichthyosis of the Sjögren-Larsson syndrome with etretinate (Tigason).
The ichthyosis of seven patients with the Sjögren-Larsson syndrome was treated with an aromatic retinoid, etretinate, during six months. Very good results were registered in six of the patients measured both as clinical improvement and as reduction in quantity of emollients needed. No unexpected side effects were noted.
D000293:Adolescent; D000328:Adult; D000368:Aged; D005050:Etretinate / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007057:Ichthyosis / Q000188:drug therapy*; D008875:Middle Aged; D011537:Pruritus / Q000139:chemically induced; D012859:Sjogren's Syndrome / Q000188:drug therapy*; D013997:Time Factors; D014212:Tretinoin / Q000031:analogs & derivatives*
D014212:Tretinoin; D005050:Etretinate